Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Magnetic Resonance Systems (MRS) was a specialized developer and manufacturer of high-performance preclinical MRI systems and components, primarily serving the life sciences and pharmaceutical research sectors. Based in Redwood City, California, the company was recognized for its innovation in compact, cryogen-free MRI technology and advanced radiofrequency (RF) coils designed for small animal imaging. Their systems enabled researchers to perform sophisticated magnetic resonance spectroscopy (MRS) and imaging (MRI) without the logistical challenges of liquid helium cooling. In 2012, the company's preclinical MRI business was acquired by Bruker Corporation, a global leader in scientific instrumentation, to strengthen its portfolio of preclinical imaging solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MRS Magnetics.